A low-nicotine cigarette maker expects about $400,000 left after product costs in Q3

22nd Century Group (XXII) reported preliminary Q3 2026 results, with revenue rising 66% to $4.8M and gross profit turning positive at $0.4M. Operating loss narrowed to $2.6M, and adjusted EBITDA loss improved to $2.2M. The company expects to release full Q3 earnings by November 13, 2026.

Original reporting
Published Oct 22, 2026, 2:35 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 2:38 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$XXII
Bearish
medium confidence
Mentioned
$XXII
Relevance
6/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$XXIIBearishLow
01

Why it matters

The preliminary loss and modest revenue suggest short‑term price pressure, but the company's unique market position could attract speculative interest.

02

Market read

Micro‑cap earnings preview with loss guidance; likely limited impact beyond the stock itself.

03

What to watch

Potential future contracts or regulatory changes could improve outlook beyond the current loss.

Relevance 6/10Novelty 6/10Timing: ahead of Q3 earnings release (before Nov 13 2026)

Background

22nd Century Group is the only low‑nicotine tobacco company, reporting unaudited Q3 figures ahead of its formal earnings release.

Company-level read

Ticker impact

$XXIIBearishMedium confidence
Context

Preliminary Q3 2026 results show $2.6M operating loss and $0.4M gross profit, new guidance for the quarter.

Expected impact

likely downside as market prices in the operating loss and weak guidance

Evidence & confidence

Small‑cap earnings preview with loss guidance typically triggers sell pressure.

Market effects

Limited impact on broader tobacco sector; low‑nicotine niche remains niche.

Primarily U.S. micro‑cap investors; no broader regional effect.

Minimal global relevance due to company size and niche market.

Counterpoint

If low‑nicotine market adoption accelerates, the loss may be temporary and could present a buying opportunity.

Key entities

  • 22nd Century Group, Inc.

    Nasdaq‑listed low‑nicotine cigarette maker (ticker XXII).

Related articles

$XXIIMed

22nd Century Group Reports Second Quarter 2026 Financial Results

22nd Century Group, Inc. (XXII) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 22nd Century Group Reports Second Quarter 2026 Financial Results Advances VLN ® Commercialization Through Expanded Retail Support and Brand-Building Initiatives MOCKSVILLE, N.C., August 13, 2026 —22nd Century Group, Inc. (Nasdaq: XXII), the leader in low-nicotine tob

$ONONMed

ON Holding earnings analysis: questions answered and next catalysts

ON Holding AG (ONON) reported Q3 2026 earnings with EPS of $0.54 (beating estimates by 42.11%) and revenue of $931.40M (in line with expectations). Despite the earnings beat, shares fell 8.07% intraday. The company has shown sequential revenue growth and consistent EPS beats, but revenue estimates have slightly declined. Next catalysts include Q4 earnings, product launches, and wholesale trends.

$RKLBMedAI 8/10

Rocket Lab earnings analysis: questions answered and next catalysts

Rocket Lab Corp (RKLB) reported Q3 FY2026 revenue of $268.0M, beating estimates, but missed earnings with EPS of -$0.12. Backlog grew to $3.6B, and Neutron launches were priced higher. The stock initially dropped but reversed, trading at $60.69. Unresolved issues include Neutron delays and cost overruns. Next catalysts include Iridium approval, Neutron progress, and Q4 results.

$OXYMedAI 8/10

Occidental Petroleum earnings analysis: questions answered and next catalysts

Occidental Petroleum (OXY) reported Q3 2026 earnings with adjusted EPS of $1.91, beating estimates by 42.5%, while revenue was $6.57B, slightly below expectations. Shares are up 35.91% YTD but down 7.25% over the past week. The company reduced debt by $1.8B in the quarter and generated $2.8B in free cash flow. Analysts remain cautious about oil price sensitivity and Gulf of Mexico production issues. Next catalysts include the Q3 earnings call on Nov 10 and Q4 earnings on Feb 24, 2027.

$IHRTHighAI 8/10

Why is iHeartMedia stock collapsing today?

iHeartMedia's stock fell 66.1% to $0.60 after Q3 2026 results missed expectations, with revenue at $1.03B (vs. $1.07B estimate) and adjusted EBITDA at $170M (vs. $201M estimate). The company cut full-year adjusted EBITDA guidance to $550M-$600M from ~$800M, citing weak broadcast radio performance and macroeconomic concerns.